Balyasny Asset Management
PTGX icon

Balyasny Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Balyasny Asset Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7M Buy
+101,299
New +$8.97M 0.02% 1006
2024
Q3 		– Hold
0
– – – 3126
2024
Q2 		– Hold
0
– – – 3036
2024
Q1 		– Sell
-50,503
Closed -$1.16M – 3038
2023
Q4 		$1.16M Buy
+50,503
New +$884K ﹤0.01% 1624
2018
Q3 		– Sell
-39,480
Closed -$265K – 1995
2018
Q2 		$265K Buy
39,480
+27,616
+233% +$212K ﹤0.01% 1554
2018
Q1 		$102K Buy
+11,864
New +$223K ﹤0.01% 1829

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return